[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"limb-fusion\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:limb-fusion":36},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":4,"maxAge":4,"enrollmentInfo":16,"targetDuration":4,"studyType":19,"phases":4,"briefSummary":20,"conditions":21,"keywords":4,"overallStatus":24,"whyStopped":4,"lastUpdateSubmitDate":25,"lastUpdatePostDateStruct":26,"startDateStruct":29,"completionDateStruct":31,"leadSponsor":33,"locationsCount":5},"100486728",false,"NCT05617846","Application of Antiosteoporosis Therapy in Osteolysis","Efficacy and Safety of Antiosteoporosis Therapy in Patients After Bone Tumor Resection: a Multicenter, Real-world Prospective Cohort Observational Study","Inclusion Criteria:\n\n1. No age restriction, male or female.\n2. A subtype of bone tumor (including benign, malignant, and metastatic cancer) was confirmed in the pathology department of the research institution.\n3. Received excision of bone tumor in research institution.\n\nExclusion Criteria:\n\nNot applicable.","ALL",{"count":17,"type":18},100,"ESTIMATED","OBSERVATIONAL","To report the postoperative complications and limb function of patients with osteolysis after surgery for bone tumors of the extremities who received anti-osteoporosis therapy in Henan Cancer Hospital in the next 10 years.",[22,23],"Limb; Fusion","Complication","NOT_YET_RECRUITING","2024-01-16",{"date":27,"type":28},"2024-01-18","ACTUAL",{"date":30,"type":18},"2024-12-28",{"date":32,"type":18},"2032-11-30",{"name":34,"class":35},"Henan Cancer Hospital","OTHER_GOV",""]